Introducing CG-100

Specifically designed to create a temporary intraluminal bypass
Aims to reduce the rate of diverting stoma by reducing the contact of fecal material with the anastomotic site

CG-100 is limited by U.S. law to investigational use and is not approved for sale or distribution in the US

Contact us

‚ÄčTEL: +972-9-7672518

FAX: +972-9-7672498


ADDRESS: 21 Atir Yeda St, Kfa Saba, 4464316 Israel